Lin HY - Search Results

1

MCAM/CD146 promotes tamoxifen resistance in breast cancer cells through induction of epithelial-mesenchymal transition, decreased ERα expression and AKT activation.

Liang YK, Zeng D, Xiao YS, Wu Y, Ouyang YX, Chen M, Li YC, Lin HY, Wei XL, Zhang YQ, Kruyt FA, Zhang GJ. Liang YK, et al. Among authors: lin hy. Cancer Lett. 2017 Feb 1;386:65-76. doi: 10.1016/j.canlet.2016.11.004. Epub 2016 Nov 9. Cancer Lett. 2017. PMID: 27838413 Free article.

2

Environmental and DNA repair risk factors for breast cancer in South China.

Fu XJ, Shi XJ, Lin K, Lin H, Huang WH, Zhang GJ, Au WW. Fu XJ, et al. Int J Hyg Environ Health. 2015 May;218(3):313-8. doi: 10.1016/j.ijheh.2015.01.001. Epub 2015 Jan 7. Int J Hyg Environ Health. 2015. PMID: 25616561

3

Notch3 overexpression causes arrest of cell cycle progression by inducing Cdh1 expression in human breast cancer cells.

Chen CF, Dou XW, Liang YK, Lin HY, Bai JW, Zhang XX, Wei XL, Li YC, Zhang GJ. Chen CF, et al. Among authors: lin hy. Cell Cycle. 2016;15(3):432-40. doi: 10.1080/15384101.2015.1127474. Cell Cycle. 2016. PMID: 26694515 Free PMC article.

4

GATA3 and TRPS1 are distinct biomarkers and prognostic factors in breast cancer: database mining for GATA family members in malignancies.

Lin HY, Zeng D, Liang YK, Wei XL, Chen CF. Lin HY, et al. Oncotarget. 2017 May 23;8(21):34750-34761. doi: 10.18632/oncotarget.16160. Oncotarget. 2017. PMID: 28423734 Free PMC article.

5

CCR10 activation stimulates the invasion and migration of breast cancer cells through the ERK1/2/MMP-7 signaling pathway.

Lin HY, Sun SM, Lu XF, Chen PY, Chen CF, Liang WQ, Peng CY. Lin HY, et al. Int Immunopharmacol. 2017 Oct;51:124-130. doi: 10.1016/j.intimp.2017.07.018. Epub 2017 Aug 19. Int Immunopharmacol. 2017. PMID: 28830025

6

Notch3 Maintains Luminal Phenotype and Suppresses Tumorigenesis and Metastasis of Breast Cancer via Trans-Activating Estrogen Receptor-α.

Dou XW, Liang YK, Lin HY, Wei XL, Zhang YQ, Bai JW, Chen CF, Chen M, Du CW, Li YC, Tian J, Man K, Zhang GJ. Dou XW, et al. Among authors: lin hy. Theranostics. 2017 Sep 20;7(16):4041-4056. doi: 10.7150/thno.19989. eCollection 2017. Theranostics. 2017. PMID: 29109797 Free PMC article.

7

Prognostic values of distinct CBX family members in breast cancer.

Liang YK, Lin HY, Chen CF, Zeng D. Liang YK, et al. Among authors: lin hy. Oncotarget. 2017 Sep 28;8(54):92375-92387. doi: 10.18632/oncotarget.21325. eCollection 2017 Nov 3. Oncotarget. 2017. PMID: 29190923 Free PMC article.

8

FoxM1 is a promising candidate target in the treatment of breast cancer.

Lu XF, Zeng D, Liang WQ, Chen CF, Sun SM, Lin HY. Lu XF, et al. Among authors: lin hy. Oncotarget. 2017 Dec 12;9(1):842-852. doi: 10.18632/oncotarget.23182. eCollection 2018 Jan 2. Oncotarget. 2017. PMID: 29416660 Free PMC article.

9

Prognostic values of the inhibitor of DNA‑binding family members in breast cancer.

Zhou XL, Zeng D, Ye YH, Sun SM, Lu XF, Liang WQ, Chen CF, Lin HY. Zhou XL, et al. Among authors: lin hy. Oncol Rep. 2018 Oct;40(4):1897-1906. doi: 10.3892/or.2018.6589. Epub 2018 Jul 23. Oncol Rep. 2018. PMID: 30066902 Free PMC article.

10

Notch3 inhibits epithelial-mesenchymal transition in breast cancer via a novel mechanism, upregulation of GATA-3 expression.

Lin HY, Liang YK, Dou XW, Chen CF, Wei XL, Zeng D, Bai JW, Guo YX, Lin FF, Huang WH, Du CW, Li YC, Chen M, Zhang GJ. Lin HY, et al. Among authors: lin ff. Oncogenesis. 2018 Aug 13;7(8):59. doi: 10.1038/s41389-018-0069-z. Oncogenesis. 2018. PMID: 30100605 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,871 results

Search Page

Filters